Cargando…
Management of Chronic Symptoms of Lyme Disease With Intravenous Ceftriaxone
Lyme disease is a vector-borne illness of North America and Europe transmitted by Borrelia burgdorferi, over 30,000 cases are reported in the United States yearly. Patients typically present having early localized disease with fevers, headaches, myalgias, and a single erythema migrans. Usually, oral...
Autores principales: | Naeem, Muhammad, Enos, Derek, Shah, Shazia, Patel, Nidhi, Fisher, Tara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359626/ https://www.ncbi.nlm.nih.gov/pubmed/34395132 http://dx.doi.org/10.7759/cureus.16354 |
Ejemplares similares
-
A Case of Confirmed Ceftriaxone-induced Immune Thrombocytopenia
por: Piedra Abusharar, Shady, et al.
Publicado: (2019) -
Ceftriaxone-Associated Severe Acute Hepatitis
por: Asif, Muhammad, et al.
Publicado: (2023) -
Ceftriaxone-Induced Reversible Agranulocytosis: A Case Report and Review of Drug-Induced Agranulocytosis
por: Munir, Farrukh, et al.
Publicado: (2022) -
Atypical Case of Lyme Neuroborreliosis With Hyponatremia
por: Rana, Dhara, et al.
Publicado: (2022) -
A Case of Tick Bite Induced Babesiosis With Lyme Disease
por: Bhesania, Siddharth, et al.
Publicado: (2021)